youtube_live
Q3 2026 earnings • in 4 days
See detailschevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.55
arrow_downward
-6.25%(-0.17) 1D
$2.55
0.00% (0.00)
todayPre-market
Closed: Nov 5, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.68
High
$2.68
Low
$2.41
Mkt. cap
391.63M
Avg. vol.
2.35M
Volume
109.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
Open
$2.68
High
$2.68
Low
$2.41
Mkt. cap
391.63M
Avg. vol.
2.35M
Volume
109.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Investing.com Canada
·
23 hours ago
Jones Trading initiates Editas Medicine stock coverage with buy rating By Investing.com
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com